On September 14, 2020, our Phoenix laboratory began performing a portion of our alternate donor antibody screen on the Ortho Clinical Diagnostics VISION Analyzer. This instrumentation change was necessary as Ortho Clinical Diagnostics will be discontinuing support of the existing ProVue instrumentation in the future.
We will notify you of the transition date of our other four laboratories. To read more about this change, click here: Communications
At CTS, we understand the impact converting to the Ortho viral marker platform has on your operation...
The CTS forms listed below have been revised with an implementation date of September 2, 2019. ...
The CTS Medical Advisory Board recently agreed upon a revision to our standard testing algorithm thi...
Reminder - Dr. Buff Mair is the new CTS Medical Director. Several of the CTS client forms specify li...
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...
As an organization dedicated to the safety of the world’s blood and plasma supply, Creative Testing...